Stagg Robert

SVP, Clinical R&D at OncoMed Pharmaceuticals Inc

Sold, on record
$16k
Dollars the filings state
Form 4 sales
3
Latest Oct 10, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale OncoMed Pharmaceuticals IncPlan not stated
    Apr 24, 2018 2018

    Sold 4,051 shares at $2.68 ($11k)

    Stagg Robert, SVP, Clinical R&D

    Sold 8.6% of holdings ($127k position)43,283 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale OncoMed Pharmaceuticals IncPlan not stated
    Oct 9, 2018 +168 days

    Sold 1,686 shares at $2.13 ($4k)

    Stagg Robert, SVP, Clinical R&D

    Sold 3.9% of holdings ($92k position)41,597 shares leftFiling

  3. 3 Form 4 sale OncoMed Pharmaceuticals IncPlan not stated
    Oct 10, 2018 +1 day

    Sold 927 shares at $2.01 ($2k)

    Stagg Robert, SVP, Clinical R&D

    Sold 2.2% of holdings ($84k position)40,670 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Stagg Robert
Source
Oct 10, 2018Oct 11, 2018OncoMed Pharmaceuticals IncSVP, Clinical R&DForm 4 sale927$2k2.2%Plan not statedSEC
Oct 9, 2018Oct 10, 2018OncoMed Pharmaceuticals IncSVP, Clinical R&DForm 4 sale1,686$4k3.9%Plan not statedSEC
Apr 24, 2018Apr 26, 2018OncoMed Pharmaceuticals IncSVP, Clinical R&DForm 4 sale4,051$11k8.6%Plan not statedSEC